*** Welcome to piglix ***

InGeneron

InGeneron Inc.
Private
Industry Health Technology, Biotechnology
Founded 2006
Headquarters Houston, Texas, United States
Area served
USA, Europe, Middle East
Key people
Ron Stubbers
(President)
Eckhard Alt
(Founder, Chairman of the Board)
Products Regenerative cell separation and diagnostic tools
Number of employees
32
Divisions
  • Wound Care
  • Aesthetics & Reconstruction
  • Orthopedics and Spine
  • Cardiovascular
  • Animal Health
Subsidiaries
  • InGeneron GmbH
  • InGeneron Equine GmbH
  • eticur) GmbH
Website www.ingeneron.com

InGeneron Inc. is a privately owned multinational medical device and biotechnology company headquartered in Houston, Texas, United States and with European headquarters in Munich, Germany. InGeneron develops, manufactures, licenses and sells regenerative cell separation and diagnostics tools. InGeneron's technologies enable the preparation of adipose-derived regenerative cells (ADRC) that contain progenitor and stem cells in humans and animals for autologous use.

InGeneron was founded in 2006, through a recapitalization of aDEPtas, Inc. in Houston, Texas with the focus on translating fundamental research in the regenerative medicine field into clinical practice. Over 40 peer-reviewed studies have been published by InGeneron's team in collaboration with various renowned academic facilities. In 2010 the fully owned subsidiary InGeneron GmbH in Munich was founded to serve as its European headquarters. In 2015 InGeneron Equine GmbH was founded in Germany, which focuses on treating orthopedic indications of sports horses. In 2015, the German-based stem cell banking company eticur) was acquired with the idea of supporting eticur) with scientific evidence from InGeneron's laboratory. In 2012, InGeneron's technology was also used to treat a Malayan tiger at the Houston zoo. In March 2017, InGeneron raised $20 million in Series D funding from Sanford Health.

InGeneron develops and manufactures biomedical equipment that is designed to fit into the workflow of an operating physician for the easy recovery of regenerative cells from the adipose tissue.

An efficient point-of-care processing system that isolates regenerative cells from adipose tissue has been developed. This system relies on a proprietary enzyme blend and centrifuge technology to isolate and prepare regenerative cells with high yield from adipose tissue within one hour after extraction.

Initial results in the veterinary space show that possible treatment areas include orthopedic injuries, osteoarthritis, incontinence, soft tissue reconstruction and non-healing wounds in animals.

Consisting of the disposables for processing and the Tissue Processing Unit, the Transpose™ RT System is InGeneron's system that allows for point-of-care preparation of regenerative cells. The collected tissue is processed with the InGeneron Tissue Processing Unit, which is a semi-automated, heatable centrifuge that is developed to process tissue prior to stem cell extraction and uses proprietary agitation to assist in the separation of the regenerative cells.


...
Wikipedia

...